Amgen | AMGN - PE Price to Earnings

Stock Price
367.80
Daily Change
1.60 0.44%
Monthly
11.40%
Yearly
23.51%
Q1 Forecast
331.35

Amgen reported $9.49 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Agios Pharmaceuticals USD 2.88 0.36 Jun/2025
ALKERMES USD 14.9 1.11 Sep/2025
Amgen USD 9.49 3.02 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Exelixis USD 16.06 4.35 Sep/2025
Genmab DKK 12.75 0.62 Sep/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
GlaxoSmithKline GBP 11.15 0.29 Dec/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
Incyte USD 17.63 2.86 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
J&J USD 23.62 0.86 Dec/2025
Merck USD 8.84 0.26 Sep/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Novartis USD 16.05 2.92 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
PTC Therapeutics USD 6.73 0.26 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
Takeda JPY 235.05 184.95 Dec/2025
Teva Pharmaceutical Industries USD 10.11 1.04 Dec/2025
Vertex Pharmaceuticals USD 23.93 3.88 Sep/2025